Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-98-001543
Filing Date
1998-02-17
Accepted
1998-02-17 00:00:00
Documents
1
Group Members
UBS (LUX) EQUITY INVEST-BIOTECHUBS ASSET MANAGEMENT NEW YORK INC
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 8056
  Complete submission text file 0000950123-98-001543.txt   9846
Mailing Address
Business Address 1345 AVENUE OF THE AMERICAS WEST 54TH & 55TH ST - 49TH FL NEW YORK NY 10105 2126497100
UBS ASSET MANAGEMENT NEW YORK INC (Filed by) CIK: 0000881153 (see all company filings)

 

Mailing Address
Business Address 3760 HAVEN AVE MENLO PARK CA 94025-1012 4158531500
NEUREX CORP/DE (Subject) CIK: 0000884065 (see all company filings)

EIN.: 770128552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42761 | Film No.: 98541027
SIC: 2836 Biological Products, (No Diagnostic Substances)